SHANTANIECE SHERRELL: Open Payments
NPI 1609203884 · AVON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,045 in 152 payments from 41 companies in 2025. Trend: 2023 $4,030 · 2024 $9,053 · 2025 $4,045
Food & beverage: $3,295Consulting: $750
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $804 |
| Merck Sharp & Dohme LLC | 11 | $332 |
| Novartis Pharmaceuticals Corporation | 22 | $298 |
| PFIZER INC. | 11 | $211 |
| Daiichi Sankyo Inc. | 9 | $201 |
| Janssen Biotech, Inc. | 7 | $195 |
| AstraZeneca Pharmaceuticals LP | 8 | $192 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $143 |
| Celgene Corporation | 5 | $97 |
| Eisai Inc. | 4 | $93 |
Products named: KEYTRUDA, Enhertu, Nubeqa, KISQALI, PADCEV, REBLOZYL, Lenvima, Trodelvy.
Industry payments across IN — which companies pay providers there.
